Generative artificial intelligence governance startup SurePath AI Inc. announced today that it has raised $5.2 million in funding to accelerate growth and enhance its platform for securely governing ...
It may seem like just yesterday, OK it was around 1997, when an HPV (human papillomavirus) test was approved for use by the FDA with a specific media— ThinPrep—as an important triage test for women ...
Generative artificial intelligence governance startup SurePath AI Inc. today announced the launch of SurePath AI Discovery, a new offering that provides rapid visibility into employee use of public AI ...
DENVER, Dec. 5, 2024 /PRNewswire/ -- SurePath AI, a leader in governing generative AI for the enterprise, today announced the launch of SurePath AI Discovery at AWS re:Invent, a new offering that ...
Roche cobas HPV Test gained U.S. Food and Drug Administration (FDA) approval for the use with SurePath Preservative Fluid to detect human papilloma virus (HPV) in cervical cells. SurePath is one of ...
microscope Roche announced that the Food and Drug Administration (FDA) has approved the cobas HPV Test, making it the first test for Human Papilloma Virus (HPV) that can be used with cervical cells ...
Funding will enable SurePath AI to bring its solutions to a broader market and mitigate risks of GenAI use in the enterprise "As GenAI adoption continues to surge across industries, businesses are ...
DENVER, May 13, 2025 /PRNewswire/ -- SurePath AI, a leader in enterprise generative AI governance, today announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback